Heartware Int'l (HTWR) Misses Q2 EPS by 23c
Tweet Send to a FriendGet Alerts HTWR Hot Sheet
Trade HTWR Now!
Heartware Int'l (NASDAQ: HTWR) reported Q2 EPS of ($1.61), $0.23 worse than the analyst estimate of ($1.38). Revenue for the quarter came in at $29.1 million versus the consensus estimate of $22.77 million.
For earnings history and earnings-related data on Heartware Int'l (HTWR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Heartware Int'l (HTWR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
- Oxford Industries (OXM) Tops Q1 EPS by 4c, Trims Top-End of FY13 Revs Outlook
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
